Review

The Art and Science of Thyroid Surgery in the Age of Genomics: 100 years after Theodor Kocher
  • Seza Gulec
Mol Imaging Radionucl Ther 2017; 26: 1-9 DOI: 10.4274/2017.26.suppl.01 PMID:28117284
18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Other Thyroid Cancers: Medullary, Anaplastic, Lymphoma and So Forth
  • Mine Araz
  • Derya Çayır
Mol Imaging Radionucl Ther 2017; 26: 1-8 DOI: 10.4274/mirt.60783 PMID:28291004
Lymph Node Dissection for Differentiated Thyroid Cancer
  • Aviram Mizrachi
  • Ashok R. Shaha
Mol Imaging Radionucl Ther 2017; 26: 10-15 DOI: 10.4274/2017.26.suppl.02 PMID:28117285
Radioactive Iodine Remnant Ablation: The Beta-knife Completion Thyroidectomy
  • Seza Gulec
  • Russ Kuker
Mol Imaging Radionucl Ther 2017; 26: 16-23 DOI: 10.4274/2017.26.suppl.03 PMID:28117286
Genomic Profiling of Thyroid Nodules: Current Role for ThyroSeq Next-Generation Sequencing on Clinical Decision-Making
  • Atil Y. Kargi
  • Marcela Perez Bustamante
  • Seza Gulec
Mol Imaging Radionucl Ther 2017; 26: 24-35 DOI: 10.4274/2017.26.suppl.04 PMID:28117287
Nuclear Medicine in Thyroid Diseases in Pediatric and Adolescent Patients
  • Bilge Volkan-Salancı
  • Pınar Özgen Kıratlı
Mol Imaging Radionucl Ther 2015; 24: 47-59 DOI: 10.4274/mirt.76476 PMID:26316469
Use of Positron Emission Tomography/Computed Tomography in Radiation Treatment Planning for Lung Cancer
  • Kezban Berberoğlu
Mol Imaging Radionucl Ther 2016; 25: 50-62 DOI: 10.4274/mirt.19870 PMID:27277321
Nuclear Molecular and Theranostic Imaging for Differentiated Thyroid Cancer
  • Arif Sheikh
  • Berna Polack
  • Yvette Rodriguez
  • Russ Kuker
Mol Imaging Radionucl Ther 2017; 26: 50-65 DOI: 10.4274/2017.26.suppl.06 PMID:28117289
I-124 Imaging and Dosimetry
  • Russ Kuker
  • Manuel Sztejnberg
  • Seza Gulec
Mol Imaging Radionucl Ther 2017; 26: 66-73 DOI: 10.4274/2017.26.suppl.07 PMID:28117290
Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer
  • Steven M. Larson
  • Joseph R. Osborne
  • Ravinder K. Grewal
  • R. Michael Tuttle
Mol Imaging Radionucl Ther 2017; 26: 80-86 DOI: 10.4274/2017.26.suppl.09 PMID:28117292
Thyroid Stimulating Hormone Receptor
  • Murat Tuncel
Mol Imaging Radionucl Ther 2017; 26: 87-91 DOI: 10.4274/2017.26.suppl.10 PMID:28117293
The Thyroid Na+/I- Symporter: Molecular Characterization and Genomic Regulation
  • Hani Alotaibi
  • Merve Tuzlakoğlu-Öztürk
  • Uygar Halis Tazebay
Mol Imaging Radionucl Ther 2017; 26: 92-101 DOI: 10.4274/2017.26.suppl.11 PMID:28117294
A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2
  • Jorge Alsina
  • Raul Alsina
  • Seza Gulec
Mol Imaging Radionucl Ther 2017; 26: 102-117 DOI: 10.4274/2017.26.suppl.12 PMID:28117295

Case Report

Detection of Isolated Diffuse Cutaneous and Subcutaneous Metastasis of Breast Cancer on FDG-PET/CT
  • Müge Öner Tamam
  • Özge Vural Topuz
  • Tugba Rezan Ekmekçi
  • Gülçin Kamali
  • Mehmet Mülazimoglu
Mol Imaging Radionucl Ther 2015; 24: 4-6 DOI: 10.4274/mirt.10820
A Case of Primary Colon Carcinoma Demonstrated by FDG PET/CT Imaging After Detection of a Solitary Brain Metastasis
  • Seval Erhamamci
  • Mehmet Reyhan
  • Gül Nihal Nursal
  • Nese Torun
  • Ali Fuat Yapar
Mol Imaging Radionucl Ther 2015; 24: 13-15 DOI: 10.4274/mirt.29491
False Positive FDG PET/CT of Recurrent Testicular Tumour Due to Orchitis
  • Robert Mansberg
  • Bao Ho
  • Chuong Bui
Mol Imaging Radionucl Ther 2014; 23: 28-30 DOI: 10.4274/Mirt.256 PMID:24653933
Evaluation of Response to Therapy in a Patient with Lung Cancer: Correlation of Sclerotic Bone Lesions with F 18 FDG PET/CT and Bone Scintigraphy
  • Tamer Özülker
  • Filiz Özülker
  • Aysun Küçüköz Uzun
  • Tarık Tatoğlu
  • Tevfik Özpaçacı
Mol Imaging Radionucl Ther 2011; 20: 29-33 DOI: 10.4274/MIRT.20.06 PMID:23486831
Concurrent Endometrial Carcinosarcoma and Thyroid Papillary Carcinoma: PET CT Imaging Findings
  • Mine Genc
  • Berhan Genc
  • Serap Karaarslan
  • Secil Kurtulmus
  • Seyhan Yalaz
  • Inanc Karapolat
Mol Imaging Radionucl Ther 2015; 24: 34-37 DOI: 10.4274/mirt.96268
Ectopic Pelvic Kidney Mimicking Sacral Metastasis on Post-Therapy Iodine-131 Scan of a Thyroid Cancer Patient
  • Selin Soyluoğlu Demir
  • Gül Ege Aktaş
  • Ahmet Polat
  • Ali Sarıkaya
Mol Imaging Radionucl Ther 2017; 26: 43-46 DOI: 10.4274/mirt.75436 PMID:28291010
Extrapulmonary Small Cell Carcinoma of the Seminal Vesicles and Prostate Demonstrated on 18F-FDG Positron Emission Tomography/Computed Tomography
  • Amir Iravani Tabrizipour
  • Lily Shen
  • Robert Mansberg
  • Bui Chuong
Mol Imaging Radionucl Ther 2016; 25: 47-49 DOI: 10.4274/mirt.02997 PMID:27299289
Laryngeal Tuberculosis Mimicking Laryngeal Carcinoma on 18F-FDG PET/CT Imaging
  • Arzu Cengiz
  • Sibel Göksel
  • Yeşim Başal
  • Şule Taş Gülen
  • Füruzan Döğer
  • Yakup Yürekli
Mol Imaging Radionucl Ther 2018; 27: 81-83 DOI: 10.4274/mirt.44366 PMID:29889030
I-131 Radiation-Induced Myelosuppression in Differentiated Thyroid Cancer Therapy
  • Stephan Probst
  • Gad Abikhzer
  • Guillaume Chaussé
  • Michael Tamilia
Mol Imaging Radionucl Ther 2018; 27: 84-87 DOI: 10.4274/mirt.59454 PMID:29889031
Unexpected Uptake by the Gallbladder in Post-Ablative I-131 Scan
  • Kemal Ünal
  • Özgür Ümit Akdemir
Mol Imaging Radionucl Ther 2015; 24: 85-86 DOI: 10.4274/mirt.57441 PMID:26316474
Sentinel Lymph Node Detection in Contralateral Axilla at Initial Presentation of a Breast Cancer Patient: Case Report
  • Gülin Uçmak Vural
  • Ilgın Şahiner
  • Semra Demirtaş
  • Hülya Efetürk
  • Bedriye Büşra Demirel
Mol Imaging Radionucl Ther 2015; 24: 90-93 DOI: 10.4274/mirt.91300 PMID:26316476
Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation?
  • Alexandra Nikaki
  • Athanasios Alexopoulos
  • Fani Vlachou
  • Vasiliki Filippi
  • Ioannis Andreou
  • Vasiliki Rapti
  • Konstantinos Gogos
  • Konstantinos Dalianis
  • Roxani Efthymiadou
  • Vassilios Prassopoulos
Mol Imaging Radionucl Ther 2016; 25: 91-96 DOI: 10.4274/mirt.22932 PMID:27277326
Sentinel Lymph Node Detection by 3D Freehand Single-Photon Emission Computed Tomography in Early Stage Breast Cancer
  • Salih Sinan Gültekin
  • Ahmet Oğuz Hasdemir
  • Serhat Tokgöz
  • Gülay Özgehan
  • Hakan Güzel
  • Cüneyt Yücesoy
  • Emine Öztürk
  • Ata Türker Arıkök
Mol Imaging Radionucl Ther 2016; 25: 97-101 DOI: 10.4274/mirt.81894 PMID:27277327
18F-NaF Positive Bone Metastases of Non 18F-FDG Avid Mucinous Gastric Cancer
  • Çiğdem Soydal
  • Elgin Özkan
  • Özlem Nuriye Küçük
  • Metin Kemal Kır
Mol Imaging Radionucl Ther 2015; 24: 132-134 DOI: 10.4274/mirt.92400 PMID:27529889

Original Research

Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Esophageal Cancer Patients
  • Çiğdem Soydal
  • Cabir Yüksel
  • Nuriye Özlem Küçük
  • İlker Ökten
  • Elgin Özkan
  • Beyza Doğanay Erdoğan
Mol Imaging Radionucl Ther 2014; 23: 12-15 DOI: 10.4274/Mirt.07379 PMID:24653929
The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer
  • Mustafa Filik
  • Kemal Metin Kir
  • Bülent Aksel
  • Çiğdem Soydal
  • Elgin Özkan
  • Özlem Nuriye Küçük
  • Erkan İbiş
  • Hikmet Akgül
Mol Imaging Radionucl Ther 2015; 24: 15-20 DOI: 10.4274/mirt.26349 PMID:25800593
Correlation of Minimum Apparent Diffusion Coefficient and Maximum Standardized Uptake Value of the Primary Tumor with Clinicopathologic Characteristics in Endometrial Cancer
  • Evrim Sürer Budak
  • Tayfun Toptaş
  • Funda Aydın
  • Ali Ozan Öner
  • Can Çevikol
  • Tayup Şimşek
Mol Imaging Radionucl Ther 2017; 26: 24-32 DOI: 10.4274/mirt.30306 PMID:28291007
18F-FLT Positron Emission Tomography/Computed Tomography Imaging in Pancreatic Cancer: Determination of Tumor Proliferative Activity and Comparison with Glycolytic Activity as Measured by 18F-FDG Positron Emission Tomography/Computed Tomography Imaging
  • Senait Aknaw Debebe
  • Mohammed Goryawala
  • Malek Adjouadi
  • Anthony J. Mcgoron
  • Seza A. Güleç
Mol Imaging Radionucl Ther 2016; 25: 32-38 DOI: 10.4274/mirt.24008 PMID:27299286
Prognostic Value of Basal Serum Thyroglobulin Levels, but Not Basal Antithyroglobulin Antibody (TgAb) Levels, in Patients with Differentiated Thyroid Cancer
  • Isa Neshandar Asli
  • Ali Shafiepour Siahkali
  • Babak Shafie
  • Hamid Javadi
  • Majid Assadi
Mol Imaging Radionucl Ther 2014; 23: 54-59 DOI: 10.4274/mirt.39200 PMID:24963446
The Evaluation of FDG PET/CT Scan Findings in Patients with Organizing Pneumonia Mimicking Lung Cancer
  • Yurdanur Erdoğan
  • Berna Akıncı Özyürek
  • Özlem Özmen
  • Nilgün Yılmaz Demirci
  • Sezgi Şahin Duyar
  • Yeliz Dadalı
  • Funda Demirağ
  • Jale Karakaya
Mol Imaging Radionucl Ther 2015; 24: 60-65 DOI: 10.4274/mirt.03016 PMID:26316470
Morphologic and Metabolic Comparison of Treatment Responsiveness with 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography According to Lung Cancer Type
  • Mehmet Fatih Börksüz
  • Taner Erselcan
  • Zekiye Hasbek
  • Birsen Yücel
  • Bülent Turgut
Mol Imaging Radionucl Ther 2016; 25: 63-69 DOI: 10.4274/mirt.36349 PMID:27277322
The Role of 18F-FDG PET/CT in the Evaluation of Gastric Cancer Recurrence
  • Hakan Cayvarlı
  • Recep Bekiş
  • Tülay Akman
  • Deniz Altun
Mol Imaging Radionucl Ther 2014; 23: 76-83 DOI: 10.4274/mirt.83803 PMID:25541930
Is Very High Thyroid Stimulating Hormone Level Required in Differentiated Thyroid Cancer for Ablation Success?
  • Zekiye Hasbek
  • Bülent Turgut
Mol Imaging Radionucl Ther 2016; 25: 79-84 DOI: 10.4274/mirt.88598 PMID:27277324
The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment
  • Tülay Kaçar Güveli
  • Sezer Özkan
  • Müge Öner Tamam
  • Ercan Uyanık
  • Nurcan Ediz
  • Mehmet Mülazımoğlu
  • Tevfik Özpaçacı
Mol Imaging Radionucl Ther 2014; 23: 84-88 DOI: 10.4274/mirt.33042 PMID:25541931
Recurrence Incidence in Differentiated Thyroid Cancers and the Importance of Diagnostic Iodine-131 Scintigraphy in Clinical Follow-up
  • Filiz Hatipoğlu
  • İnanç Karapolat
  • Özgür Ömür
  • Ayşegül Akgün
  • Ahmet Yanarateş
  • Kamil Kumanlıoğlu
Mol Imaging Radionucl Ther 2016; 25: 85-90 DOI: 10.4274/mirt.35220 PMID:27277325
The Evaluation of Microcarcinoma in Differentiated Thyroid Cancers According to Old and New TNM Classification
  • Zekiye Hasbek
  • Bülent Turgut
  • Taner Erselcan
  • Ayhan Koyuncu
  • Mehmet Fatih Börksüz
  • Nergiz Hacer Turgut
  • Fadime Yumuk
Mol Imaging Radionucl Ther 2011; 20: 94-99 DOI: 10.4274/MIRT.13 PMID:23486990
The Effect of the Excisional Biopsy in the Detection of the Sentinel Lymph Node By Lymphoscintigraphy and Intraoperative Gamma Probe in Breast Cancer
  • Pelin Arıcan
  • İrfan Peksoy
  • Seniha Naldöken
  • Betül Bozkurt
Mol Imaging Radionucl Ther 2011; 20: 100-103 DOI: 10.4274/MIRT.28 PMID:23486641
The Diagnostic Value of the Correlation between Serum Anti-p53 Antibody and Positron Emission Tomography Parameters in Lung Cancer
  • Zekiye Hasbek
  • Ömer Tamer Doğan
  • İsmail Sarı
  • Birsen Yücel
  • Mehmet Metin Şeker
  • Bülent Turgut
  • Serdar Berk
  • Yavuz Siliğ
Mol Imaging Radionucl Ther 2016; 25: 107-113 DOI: 10.4274/mirt.97269 PMID:27751972
Does Metastatic Lymph Node SUVmax Predict Survival in Patients with Esophageal Cancer?
  • Betül Vatankulu
  • Yasemin Şanlı
  • Esra Kaytan Sağlam
  • Serkan Kuyumcu
  • Zeynep Gözde Özkan
  • Ebru Yılmaz
  • Sevim Purisa
  • Işık Adalet
Mol Imaging Radionucl Ther 2015; 24: 120-127 DOI: 10.4274/mirt.36744 PMID:27529887

Case Reports

Is Every Patient Followed up as a Papillary Thyroid Cancer Patient Really That?
  • Ummuhan Abdulrezzak
  • Ahmet Tutus
  • Mustafa Kula
  • Figen Öztürk
  • Işın Soyuer
Mol Imaging Radionucl Ther 2012; 21: 38-41 DOI: 10.4274/Mirt.022866 PMID:23487501

Case Reports

Rare Thyroid Cartilage and Diaphragm Metastases from Lung Cancer Visualized on F-18 FDG-PET/CT Imaging
  • Pelin Özcan Kara
  • Gonca Kara Gedik
  • Oktay Sarı
  • Orhan Özbek
Mol Imaging Radionucl Ther 2011; 20: 70-72 DOI: 10.4274/MIRT.019882 PMID:23486533

About Journal

Forms

Useful Links

Applications